Home / Business and Economy / Tata Elxsi Powers Cardiac Innovation with Terumo ODC
Tata Elxsi Powers Cardiac Innovation with Terumo ODC
19 Mar
Summary
- New offshore development center supports advanced cardiac solutions.
- Center integrates AI and GenAI for faster innovation and efficiency.
- Partnership aims to enhance product development speed and compliance.
Tata Elxsi announced on March 19, 2026, the inauguration of a global offshore development center (ODC) for the Tokyo-based Terumo Corporation. This new facility is designed to significantly enhance the development of advanced cardiac and vascular solutions.
The 'Terumo-Tata Elxsi Offshore Development Center' will provide comprehensive support for engineering, innovation, and end-to-end lifecycle management of Terumo's medical technologies. The collaboration is poised to expedite product development timelines while rigorously adhering to global regulatory standards.
Multidisciplinary teams at the ODC will harness Tata Elxsi's expertise in design, engineering, verification, and regulatory compliance. The integration of AI and GenAI into software engineering processes is expected to foster quicker innovation and greater product differentiation.
This strategic partnership concentrates on elevating the performance and reliability of cardiac and vascular devices, responding to the increasing worldwide demand for patient-focused medical solutions. Shares of Tata Elxsi saw a 4% decrease, closing at ₹4,039.30 on the NSE on March 19, 2026.
